Listed

CVS HEALTH Corp: Form 10-K for the period ended Dec 31, 2017

Filed with the SEC on Feb 14, 2018 and accepted by EDGAR at Feb 14, 2018, 17:30 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2017-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2017-10-01 to 2017-12-31$48.38bnus-gaap:Revenues
Cost of revenue12 months2017-01-01 to 2017-12-31$156.22bnus-gaap:CostOfRevenue
Gross profit3 months2017-10-01 to 2017-12-31$7.90bnus-gaap:GrossProfit
Gross profit12 months2017-01-01 to 2017-12-31$28.55bnus-gaap:GrossProfit
Operating income3 months2017-10-01 to 2017-12-31$3.11bnus-gaap:OperatingIncomeLoss
Operating income12 months2017-01-01 to 2017-12-31$9.52bnus-gaap:OperatingIncomeLoss
Interest expense12 months2017-01-01 to 2017-12-31$1.06bnus-gaap:InterestExpense
Income tax12 months2017-01-01 to 2017-12-31$1.64bnus-gaap:IncomeTaxExpenseBenefit
Net income3 months2017-10-01 to 2017-12-31$3.29bnus-gaap:NetIncomeLoss
Net income12 months2017-01-01 to 2017-12-31$6.62bnus-gaap:NetIncomeLoss
Diluted EPS3 months2017-10-01 to 2017-12-31$3.22us-gaap:EarningsPerShareDiluted
Diluted EPS12 months2017-01-01 to 2017-12-31$6.44us-gaap:EarningsPerShareDiluted
Basic EPS3 months2017-10-01 to 2017-12-31$3.23us-gaap:EarningsPerShareBasic
Basic EPS12 months2017-01-01 to 2017-12-31$6.47us-gaap:EarningsPerShareBasic
Diluted shares (weighted)12 months2017-01-01 to 2017-12-311,024,000,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow12 months2017-01-01 to 2017-12-31$8.01bnus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2017-01-01 to 2017-12-31$1.92bnus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid12 months2017-01-01 to 2017-12-31$2.05bnus-gaap:PaymentsOfDividends
Share repurchases12 months2017-01-01 to 2017-12-31$4.36bnus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2017-12-31$1.70bnus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2017-12-31$31.23bnus-gaap:AssetsCurrent
Total assetsAt period end2017-12-31$95.13bnus-gaap:Assets
Current liabilitiesAt period end2017-12-31$30.65bnus-gaap:LiabilitiesCurrent
Long-term debtAt period end2017-12-31$22.18bnus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2017-12-31$3.54bnus-gaap:LongTermDebtCurrent
Short-term borrowingsAt period end2017-12-31$1.28bnus-gaap:ShortTermBorrowings
Shareholders' equityAt period end2017-12-31$37.69bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001558370-18-000707. Last ingested by Listed: Nov 6, 2026, 17:47 ET. Listed shows no prices and gives no investment advice.